Mark McClellan Quotations

Since January, we've seen a steady, increasing rate of enrollment, and we expect to continue seeing that until May 15.

Food choices affect health outcomes, and consumers need to have the latest, most up-to-date scientific information in making their food choices.

Pharmacogenomics holds great promise to shed scientific light on the often risky and costly process of drug development, and to provide greater confidence about the risks and benefits of drugs in specific populations. Pharmacogenomics is a new field, but we intend to do all we can to use it to promote the development of medicines. By providing practical guidance on how to turn the explosion of pharmacogenomic information into real evidence on new drugs, we are taking an important step toward that goal.

Every day we're seeing more and more people get their prescription drugs smoothly, and we have other steps in place to make sure that anyone who is having difficulty can get the drugs they need.

It's time for people with Medicare and those who care about them to start thinking about making Medicare decisions. And we will help them.

We've seen enrollment continue at a steady pace, faster than what we saw before the late December surge.

We will reduce the wait times for beneficiaries and pharmacists in order to avoid any beneficiary leaving the pharmacy without prescriptions.

The challenge in policymaking is to take all the steps we can to help avoid unnecessary costs, to help people save money, to drive costs down wherever possible. That's the way to have both affordability and better and better health care.

When you look at the people who say they don't plan to enroll, it's mainly because they already have coverage. They have coverage through a former employer or through a Medicare health plan, and that's just great.

Many people were expecting significant reduction in retiree coverage, which just hasn't happened.